A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.

Published in:

PLoS Neglected Tropical Diseases, 2021, v. 15, n. 11, p. 1, doi. 10.1371/journal.pntd.0009969

By:

• Erdem, Rahsan;
• Ambler, Gwen;
• Al-Ibrahim, Mohamed;
• Fraczek, Katarzyna;
• Dong, Steven D.;
• Gast, Christopher;
• Mercer, Laina D.;
• Raine, Michael;
• Tennant, Sharon M.;
• Chen, Wilbur H.;
• de Hostos, Eugenio L.;
• Choy, Robert K. M.

Publication type:

Article